Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Intel Corp (INTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Intel Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Intel Corp trades at $94 (market cap $518.67B). The key difference: Intel Corp is far larger — about 16.8× GE HealthCare Technologies Inc. Common Stock's market cap, and Intel Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| GEHC | INTC | |
|---|---|---|
Market Cap | $30.93B | $518.67B |
Volume | 5,033,451 | 103,750,027 |
Sector | Health | Technology |
52-Week High | $88.16 | $140.94 |
52-Week Low | $59.48 | $33.62 |
Enterprise Value | $39.39B | $539.48B |
Dividend Yield | 0.23% | 2.24% |
Typical Hold Time | — | 116 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Intel (INTC) trades at $102.81, up 1.44% with strong recent earnings beats but faces fundamental challenges including negative net income margin of -19.79% and elevated P/E ratio of 904.17. The stock has shown impressive 2026 momentum with three consecutive quarterly EPS beats, while technical indicators show mixed signals with bearish moving averages but bullish oscillators. Recent news highlights Intel's foundry turnaround efforts and 220% stock surge in 2026, though competition remains intense.
Intel presents a turnaround story with significant execution risks. The foundry business shows growth potential with 31% revenue increase, but negative profitability metrics and high valuation ratios suggest caution. Analyst consensus leans neutral with 54% hold ratings, while the $111.72 price target offers modest upside. Key risks include competitive pressures from TSMC and AMD, margin challenges, and the sustainability of recent stock gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
